[Intraperitoneal administration of drugs in patients treated with peritoneal dialysis].
Grzegorzewska
A E
AE
Klinika Nefrologii Instytutu Chorób Wewnetrznych Akademii Medycznej im. Karola Marcinkowskiego w Poznaniu.
D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000737:chemistry; D002117:Calcitriol / Q000008:administration & dosage; D002121:Calcium Channel Blockers / Q000008:administration & dosage; D016207:Cytokines / Q000008:administration & dosage; D015314:Dialysis Solutions / Q000737:chemistry; D004355:Drug Stability; D004921:Erythropoietin / Q000008:administration & dosage; D006801:Humans; D007213:Indomethacin / Q000008:administration & dosage; D007274:Injections, Intraperitoneal / Q000379:methods*; D007328:Insulin / Q000008:administration & dosage; D010530:Peritoneal Dialysis / Q000009:adverse effects*; D010538:Peritonitis / Q000209:etiology / Q000517:prevention & control*
D000900:Anti-Bacterial Agents; D002121:Calcium Channel Blockers; D016207:Cytokines; D015314:Dialysis Solutions; D007328:Insulin; D004921:Erythropoietin; D002117:Calcitriol; D007213:Indomethacin
Dootrzewnowe podawanie leków u chorych leczonych dializa otrzewnowa.